Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat, and other poultry products. Veterinary biologics are governed by the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics. To combat increasing prevalence of potentially fatal veterinary diseases, there’s a significant spike in demand for combination vaccines that allow for greater accuracy and stability of the finished product. Regulations are also focusing on improving stability, consistency and quality of vaccines produced. Maintaining the quality of production will circumvent risk of side effects.
As per the American Veterinary Medical Foundation, core vaccines such as rabies, feline viral rhinotracheitis, feline panleukopenia, canine parvovirus infection, and canine hepatitis are recommended for every pet, while non-core vaccines such as canine kennel cough and feline leukemia are recommended based on specific needs of the animal. However, low awareness among pet owners and livestock managers inhibits the growth of veterinary vaccines market, especially in emerging economies.
The global veterinary vaccines market was valued at US$ 5,688.7 million in 2015 and is expected to witness a moderate CAGR of 5.9% during the forecast period (2016 – 2024).
Figure 1. Global Veterinary Vaccines Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024
Source: Coherent Market Insights Analysis (2017)
To have a snippet of the report, request Report Sample
Increasing incidence of veterinary diseases to drive the growth of veterinary vaccines market
According to the 2015 Global Animal Disease Intelligence Report by the Food and Agriculture Organization (FAO), prevalence of foot-and-mouth disease (FMD) was especially high in Morocco, Saudi Arabia, Turkey, Northern, and Southern Africa. Ebola (Zoonotic disease) continued to be prevalent in West Africa. Also, rabies that leads to thousands of human deaths worldwide is prevalent in 150 countries according to the WHO, with highest number of related deaths reported in Asia and Africa. Thus, these regions are amongst the largest target regions for veterinary vaccines market. Incidence rate of rabies has reduce drastically in Latin America and Caribbean regions due to successful implementation dog rabies control programs.
Growing pet adoption and livestock animals to improve the veterinary vaccines market outlook
As per 2016 Pet Secure (a pet rescue organization in Australia) estimates, dog population is highest in the U.S. at 69,929,000. Pet owners in the country spend over US$ 50 billion on maintenance of their pets. However, pet adoption in Asia Pacific and Latin America regions is increasing rapidly according to the Pet Asia Fair in 2016, resulting in increase in demand for vaccines in these regions. China, Russia and Brazil are leading countries in terms of cat and dog population as per the 2016 estimates of Pet Secure. Also, the organization mentions that the population of dogs in Switzerland is shrinking while increasing rapidly in India. These regional trends of pet adoption need to be essentially factored for by the companies to increase share in the global veterinary vaccines market.
Evolving technology improving the affordability of veterinary vaccines
Cell culture has enabled mass production of vaccines. Adoption of cell culture technology for parenteral veterinary vaccine production is increasing in emerging economies in Asia as per the World Health Organization (WHO). Highly immunogenic inactivated cell culture parenteral vaccines for dogs are now available at an affordable costs in emerging economies. Moreover, according to the WHO, trials for oral immunization of dogs are underway in these regions. This is expected to benefit one of the larger section of veterinary vaccination consumer base. Also, third generation vaccines are being produced using recombinant technology. Increasing implantation of advanced production technologies is expected to significantly decrease costs of veterinary vaccines and in turn increase their adoption in cost-sensitive emerging economies characterized by large pet and livestock population.
Veterinary/Animal vaccines are parenteral products that are used as prophylactic as well as in treatment of various veterinary diseases. Veterinary vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. It also plays an extremely important role in curtailing incidence of transmission of various diseases from animals to humans. Vaccines are broadly classified as inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, subunit and DNA vaccines. Inactivated vaccines are considered as safe vaccines, though they contain extraneous proteins or adjuvants, which can increase risk for development of acute vaccine reactions. Veterinary vaccines impact animal health and production quality and also help ensure good health of general human population through consumption of various food procured from animals. The continued interaction between animals and health professionals are the major importance for adaption of novel technologies in heath sector by providing animal models of disease.
Rapid increase in population of companion animals and livestock animals globally is one of the major factors expected to favor market growth for veterinary vaccines. Rise in awareness about the vaccination programs are further favoring growth of the global veterinary vaccines market. The market is estimated to witness considerable revenue traction over the forecast period, due to increasing incidence of food-borne zoonotic diseases worldwide. Also, rise in demand for white meat in the North American and European countries is in turn expected to support growth of the veterinary vaccines market in the near future. According to the PoultrySite - Poultry News, Health, Welfare, Diseases, Markets and Economics, in 2013, there was a significant rise in demand for white meat in Italy since a decade, with demand for turkey, chicken and eggs increased by 8.5%, while production of poultry increased by 16%.
This report segments the global veterinary vaccines market on the basis of technology, animal type and geography. On the basis of product type, the market is categorized into inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, subunit and DNA vaccines. On the basis of animal type, the market is segmented into companion animal and livestock animal. The companion animal type segment is sub-segmented into equine, canine, and feline. The livestock animal type segment is further sub-segmented into bovine, ovine, porcine, poultry and other animals. For comprehensive understanding of market dynamics, the global veterinary vaccines market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Request Report Sample for more Professional and Technical Insights.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 40 market data tables and 25 figures on "Veterinary Vaccines Market - Global forecast to 2024”.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.